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Abstract
We have investigated the contribution of individual phosphoinositide 3-kinase (PI3K) Class I isoforms to the regulation of
neutrophil survival using (i) a panel of commercially available small molecule isoform-selective PI3K Class I inhibitors, (ii)
novel inhibitors, which target single or multiple Class I isoforms (PI3Ka, PI3Kb, PI3Kd, and PI3Kc), and (iii) transgenic mice
lacking functional PI3K isoforms (p110dKOcKO or p110cKO). Our data suggest that there is considerable functional
redundancy amongst Class I PI3Ks (both Class IA and Class IB) with regard to GM-CSF-mediated suppression of neutrophil
apoptosis. Hence pharmacological inhibition of any 3 or more PI3K isoforms was required to block the GM-CSF survival
response in human neutrophils, with inhibition of individual or any two isoforms having little or no effect. Likewise, isolated
blood neutrophils derived from double knockout PI3K p110dKOcKO mice underwent normal time-dependent constitutive
apoptosis and displayed identical GM-CSF mediated survival to wild type cells, but were sensitized to pharmacological
inhibition of the remaining PI3K isoforms. Surprisingly, the pro-survival neutrophil phenotype observed in patients with an
acute exacerbation of chronic obstructive pulmonary disease (COPD) was resilient to inactivation of the PI3K pathway.
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Introduction
Neutrophils are terminally differentiated, short-lived innate
immune cells, which contain an arsenal of cytotoxic agents
essential for pathogen clearance. If activated inappropriately these
microbicidal mechanisms can result in significant tissue injury [1].
Hence, neutrophil-mediated tissue damage plays a cardinal role in
the pathogenesis and progression of several diseases, including
acute respiratory distress syndrome (ARDS) [2], cystic fibrosis (CF)
[3], and chronic obstructive pulmonary disease (COPD) [4].
Apoptosis controls neutrophil longevity in tissues and is critical to
the resolution of granulocyte inflammation [5,6]. Neutrophils
undergo rapid constitutive apoptosis, and survival is contingent on
the balance of pro-survival and pro-apoptotic signals derived from
the micro-environment. The growth factor granulocyte-macro-
phage colony stimulating factor (GM-CSF) drives the aberrant
neutrophil survival response observed in patients with ARDS and
ventilator-associated pneumonia [5,7], both common causes of
death in Intensive Care Units. In animal models of lung
inflammation, pharmacological acceleration of neutrophil apopto-
sis promotes the resolution of inflammation [6].
Class I PI3Ks play a critical role in transducing signals from
cytokines, chemokines and growth factors by catalyzing the
synthesis of key lipid-based second messengers, particularly
phosphatidylinositol-3,4,5-trisphosphate (PtdIns(3,4,5)P3). This
leads to engagement of downstream effectors such as PKB (Akt)
and PDK1, which regulate fundamental cellular processes related
to cell growth, proliferation, adhesion, migration and survival,
reviewed in [8]. Structurally, Class I PI3Ks are heterodimers,
comprising a 110 kDa catalytic subunit p110 (a, b, d or c) and an
adaptor subunit (p55/p85 or p84/p101). Class I PI3Ks are
subdivided into IA and IB; Class IA consist of p110a, b and d,
which associate with the p85 or p55 adaptor and are generally
activated through receptor tyrosine kinases. By contrast, Class IB
PI3Ks consists solely of p110c, which associates with p101 or p84
adaptor subunits and is stimulated by the bc subunits of G-protein
coupled receptors. Class I PI3K heterodimers are conventionally
named only by their catalytic subunit, thus PI3Ks a, b, d or c refer
to dimers containing p110a, b, d or c, respectively.
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There is evidence from multiple cells lines that individual Class I
PI3K isoforms can play unique signaling roles in a variety of
biological processes, reviewed in [9]. The p110d and c isoforms
are enriched in immune cells (including neutrophils) [10] and are
integral to leukocyte function. Mice lacking functional p110c show
impaired neutrophil and macrophage migration, reduced neutro-
phil oxidative burst activity, mast cell degranulation, and impaired
B-cell and thymocyte development [11–14]. The PI3Kc isoform
has also been reported to exert significant anti-apoptotic effects in
neutrophils even under basal conditions [15,16]. PI3Kd con-
tributes to neutrophil chemotactic responses [17], their recruit-
ment to inflammatory foci [18], and to the human (but not
murine) neutrophil respiratory burst [10]. PI3Kb has recently
been shown to play a selective role downstream of neutrophil Fcc
receptors [19]. These PI3K isoforms consequently represent
attractive therapeutic targets in inflammation and a number of
inhibitors have already entered Phase I clinical trials.
Recently, Foukas et al. [20] demonstrated that signaling
through any PI3K Class IA, but not class IB, could sustain
survival in hemopoietic progenitor cells following treatment with
IL-3. However, it is well established that immortalized cells exhibit
dysregulated intracellular signaling and behave differently to
primary cells [21]. Although multiple interdependent survival
pathways co-exist in neutrophils, we have previously demonstrated
that GM-CSF-mediated neutrophil survival is .85% PI3K-
dependent [22]. Given recent evidence of PI3K isoform-specific
roles, we wished to investigate the relative contribution of
individual Class I PI3K isoforms to constitutive neutrophil
apoptosis and the cytoprotective effect of GM-CSF. We used
a panel of novel small molecule inhibitors and transgenic mice
lacking one or more functional PI3K isoforms (p110dKOcKO or
p110cKO). We report near-complete functional redundancy of the
PI3K Class I isoforms in mediating the GM-CSF survival effect in
both human and murine peripheral blood neutrophils, necessitat-
ing combined inhibition of at least three PI3K Class I isoforms to
block the pro-survival effect of GM-CSF. With regard to the
potential for modulation of neutrophil apoptosis in human disease
states, we observed a clear neutrophil survival phenotype in
patients experiencing an exacerbation of COPD, which was
completely resistant to PI3K inhibition.
Materials and Methods
Ethics Statement
All human participants gave written informed consent, and all
studies complied with the Declaration of Helsinki. Human
peripheral blood neutrophils were purified from healthy human
volunteers (ethical approval UK06/Q0108/281). Neutrophils
were also isolated from the peripheral blood of patients admitted
to hospital suffering from a non-infective acute exacerbation of
COPD (ethical approval UK08/H0308/281). All animal studies
were performed following approval by the UK Home Office
Animals (Scientific Procedures) Act 1986 and in accord with the
conditions specified in Project License PPL 80/2335.
Mouse Strains
Mouse strains with deletions in the PI3Kc (p110cKO) or PI3Kc
and d catalytic subunits (p110dKOcKO ) were bred on a C57BL/6
background for at least 6 generations [14]. In all relevant
experiments, neutrophils from these mutant strains of mice were
compared with cells derived from appropriate strain-matched
wild-type C57BL/6 controls. All mice were housed in the small
animal barrier unit (SABU) at the Babraham Institute under
specific pathogen-free conditions. Mouse husbandry and experi-
mentation were conducted in accordance with UK Home Office
Project License PPL 80/2335. Mice aged 12–16 weeks were
terminally anesthetized using an intraperitoneal injection of
fentanyl citrate (Vet Pharma) and midazolam (Roche).
Isolation of Human Peripheral Blood Neutrophils from
Healthy Volunteers and Patients with COPD
Human peripheral blood neutrophils were purified from healthy
human volunteers (ethical approval UK06/Q0108/281) by
dextran sedimentation and centrifugation through plasma/Percoll
gradients. Cell purity was consistently greater than 97%
neutrophils as assessed using cytocentrifuge preparations fixed in
methanol and stained with DiffQuickTM. Neutrophils were also
isolated from the peripheral blood of patients admitted to hospital
suffering from a non-infective acute exacerbation of COPD
(ethical approval UK08/H0308/281) with written informed
consent. Details of patients with COPD are given in Table 1.
All patients recruited had COPD defined according to GOLD
criteria stage 2–3 as judged by post-bronchodilator spirometry
when stable, and an exacerbation requiring hospital admission.
Patients taking long term oral corticosteroids or those who had
been treated in the community for more than 48 hours prior to
admission were excluded, as were those with consolidation on
a chest radiograph, an elevated C-reactive protein level, or sputum
cultures positive for bacterial pathogens. All patients received
nebulised bronchodilators and oral corticosteroids from the time of
admission; other treatment was at the discretion of the attending
physician. None of the patients studied required mechanical
ventilation. Patients were venesected within 48 hours following
hospitalization and a further sample obtained following discharge
within 14 days of admission; by this point all patients were judged
to have been clinically stable for at least 5 days. Of the patients
recruited, one self-discharged from hospital within 5 days of
admission and did not complete the study.
To examine the effects of small molecule PI3K inhibitors on
rhGM-CSF (10 ng/ml) -modulated apoptosis, neutrophils
(56106/ml) were re-suspended in Iscove’s modified Dulbecco
medium (IMDM) supplemented with 10% autologous serum,
100 U/mL penicillin and 100 mg/mL streptomycin in non-tissue
culture treated flat bottom Falcon Flexiwell plates in a humidified
5% CO2 atmosphere at 37uC. Cells were pre-incubated for 20
minutes with DMSO vehicle control, LY294002 (10 mM);
wortmannin (1 mM), PI-103(10 mM), YM-024 (3 mM), TGX-221
(10 mM), IC871184 (3 mM) or AS605240 (10 mM), or 1 mM of
each of the Novartis PI3K inhibitors NVS-PI3-3, HBC-417, NVS-
PI3-2 and NVS-PI3-4 (chemical structure, Figure 1) prior to
treatment with rhGM-CSF (10 ng/ml). Wortmannin was replen-
ished at 4, 8 and 12 hours to overcome its lack of stability in
aqueous solution.
Isolation of Murine Peripheral Blood Neutrophils
Studies were performed in accordance with the Project License
PPL 80/2335. Blood (800 ml 6100 ml) was collected from the
inferior vena cava of terminally anesthetized mice using a hepa-
rinized syringe; 100 ml was anti-coagulated with EDTA to perform
peripheral blood counts by blood films and by using the
Hematology Cell Counter MS9-5 (Mellet Schloesing Laboratories,
France) (Table 2).
The remaining blood was transferred into dextran (3 ml, 1.25%
w/v in saline) as previously described [23]. The tubes were topped
up to 10 ml with dextran solution and the erythrocytes sedimented
at room temperature for 30 minutes. The leukocyte-rich
supernatant was washed in buffer (sterile-filtered PBS without
cations, containing 0.3% w/v low-endotoxin BSA, pH 7.4).
Regulation of Neutrophil Apoptosis by PI3Ks
PLOS ONE | www.plosone.org 2 September 2012 | Volume 7 | Issue 9 | e45933
Neutrophils were then negatively selected by incubating with the
following antibodies: for lymphocytes, anti-CD2 (BD Biosciences
553109), -CD5 (BD Biosciences 553017) and -CD45R (BD
Biosciences 553083), and for monocytes anti-F4/80 (Serotec
MCAP497) and CD 115 (Serotec MCA1898XZ) as described,
[23]. The final neutrophil yield was ,0.76106 cells from each
mouse. Cell purity was assessed by differential counts of
cytocentrifuge preparations and by flow cytometry; samples of
9065% purity were obtained for all reported experiments.
Viability of freshly isolated neutrophils was consistently above
97% as assessed by both trypan blue staining and flow cytometry
with propidium iodide.
Neutrophils were cultured at 1.06106/ml in Roswell Park
Memorial Institute medium-1640 (RPMI), 10% heat inactivated
fetal bovine serum (FBS) with 20 mM HEPES, and penicillin and
streptomycin in the presence of various treatments in Flexiwell
plates at 37uC in a 5% CO2 atmosphere.
Morphologic Analysis of Neutrophil Apoptosis
Neutrophils were harvested from the 96-well at the time points
indicated; human neutrophils were cytocentrifuged for 3 minutes
at 300 rpm at high acceleration (murine neutrophils for 6 minutes
at 900 rpm and low acceleration) onto PolysineTM microscope
slides using a Shandon Cytospin 3 (Shandon, UK) then fixed in
methanol and stained with DiffQuickTM. Neutrophil apoptosis was
assessed by cell morphology under light microscopy using a640 or
6100 objective. Apoptotic neutrophils were identified by cell
shrinkage, blebbing of the cell membrane and the presence of
darkly stained, condensed and fragmented nuclei. For each
condition, triplicate slides were prepared and 300 neutrophils
counted per slide in a blinded fashion. Brightfield images of the
cytocentrifuge preparations were captured through the 6100 oil
immersion objective SPlanApo 1.4 NA on the Olympus BX41
light microscope using Micropublisher 3.3 (Qimaging) camera and
Q Capture-Pro (Qimaging) software.
Flow Cytometry Analysis of Neutrophil Apoptosis
Neutrophils were harvested at the time points indicated and
centrifuged (275 g, 1 minute) then re-suspended in 200 ml HEPES
(N-2-hydroxyethylpiperazine-N’-2-ethanesulfonic acid) buffer
(10 mM HEPES-NaOH, pH 7.4, 150 mM NaCl, 5 mM KCl,
1 mM MgCl2, 1.8 mM CaCl2) containing annexin-V-fluorescein
isothiocyanate (FITC) (1 mg/ml) and propidium iodide (10 mg/
ml). Samples were incubated for 20 minutes at 4uC in the dark,
and the volume increased to 500 ml with HEPES buffer
immediately before analysis using a fluorescence-activated cell
sorter (FAC Calibur; Becton Dickinson, UK) with CellQuest
software. Ten thousand events were collected for each sample, and
data analyzed using FlowJo6.4.7 software. Viable, non-apoptotic
neutrophils were defined as negative for both annexin V-FITC
and PI, and apoptotic neutrophils were defined as positive for
annexin V-FITC. Apoptosis was expressed as a percentage of
apoptotic neutrophils in relation to the total number of counted
neutrophils.
Confocal Imaging
Freshly isolated neutrophils were incubated in the dark at 37uC
either with the cationic mitochondrial dye 5, 59, 6, 69-tetrachloro-
1,19,3,39-etraethylbenzimidazocarbocyaniniodide (JC-1, 10 mg/
ml), or with annexin V-FITC and propidium iodide as described
above, prior to imaging. Live-cell confocal images of murine
peripheral blood neutrophils were obtained using cells cultured on
sterile poly-lysine coated glass cover slips at 1.06106/ml in
Roswell Park Memorial Institute medium-1640 (RPMI), 10% heat
inactivated fetal bovine serum (FBS) with 20 mMHEPES at 37uC.
Images were captured using an Olympus CellR imaging system
comprising an Olympus IX81 microscope, Olympus MT-20
illumination system, Olympus 6100 SPlanApo 6100 1.45 NA
objective, Hamamatsu Orca ER camera, and Olympus SIS
software. For alexafluor 488-labelled annexin and PI, red/green
images were taken every 10 minutes over 12 hours using a 300 ms
exposure time and excitation intensity at 4% for both fluorescence
channels; for JC-1, red/green images were taken using a 250 ms
exposure time and excitation intensity set to 3% for both
fluorescence channels. For both annexin/PI and JC-1 experiments
transmitted light images were automatically captured in sequence
with the fluorescence images using standard differential interfer-
ence contrast optics.
Western Blot Analysis for Akt Phosphorylation
Neutrophils were suspended at 56106/ml and 0.5 ml aliquots
were pre-incubated for 20 minutes with PI3K inhibitors at 37uC
prior to treatment with GM-CSF 10 ng/ml for 10 min. The cells
were washed with ice-cold phosphate-buffered saline and pelleted
and resuspended in 50 ml of cold lysis buffer (20 mM Tris-HCl
(pH 7.5), 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton
X-100, 2.5 mM sodium pyrophosphate, 1 mM b-glyceropho-
sphate, 1 mM PMSF, 1 mM sodium fluoride, 2 mM sodium
orthovanadate, 10 mg/ml leupeptin, 10 mg/ml aprotinin) and
incubated on ice for 10 minutes. The Triton-insoluble fraction was
pelleted by centrifugation at 10 000 g for 15 min at 4uC. The
protein concentration of the supernatant was determined using
a colorimetric assay (bicinchoninic acid; BCA, BIO Rad
Laboratories). SDS sample buffer was added to each neutrophil
lysate and heated to 99uC for 5 min. 30 mg of protein/well was
loaded on to each 10% SDS-polyacrylamide gel and subjected to
electrophoresis at 150 V and transferred to a PVDF Immobilon
membrane using a semi-dry transfer system at 130 mA for 90
minutes. The membrane was blocked for 1 hour with 5% non-fat
dry milk in Tris-HCl buffered saline containing 0.1% (w/v) Tween
Table 1. Demographic profile of the patients with chronic obstructive pulmonary disease (COPD).
COPD Patient Age (yrs) Smoking status FEV1/FVC ratio (%) CXR WBC (6109/L) CRP (mg/L)
1 50 Current 60.3 Hyperinflated 10.1 3
2 80 Current 30.6 Cardiomegaly 12.3 6
3 70 Ex-smoker 57.1 Normal 15.5 6
4 68 Ex-smoker 63.5 Cardiomegaly 10.9 8
5 63 Current 38.9 Hyperinflated 8.1 6
doi:10.1371/journal.pone.0045933.t001
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20 then immunoblotted overnight at 4uC in TBS-Tween-20 with
primary monoclonal antibody to total Akt rabbit mAb or
Phospho-Akt (Ser473) rabbit mAb (Cell Signaling Technology
40585 and 9272 respectively) at a dilution of 1:1000 in TBS-
Tween 20 with 5% Bovine Serum Albumin. The membrane was
washed three times in TBS-Tween 20 and incubated with ECL
Figure 1. Molecular structures of NVS-PI3-2 (a inhibitor), HBC-417 (b inhibitor), NVS-PI3-3 (d inhibitor) and NVS-PI3-4 (c inhibitor).
doi:10.1371/journal.pone.0045933.g001
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HRP-conjugated donkey anti-rabbit IgG (Fab2 fragment; GE
Healthcare) at a dilution of 1:10 000 in TBS-Tween 20 for 1 hour
at room temperature. Membranes were developed using ECL-Plus
kit (GE Healthcare).
Small Molecule Inhibitors and Cytokines
All PI3K inhibitors were dissolved in dimethyl sulfoxide
(DMSO) and stored at 220uC. Recombinant human (rh) GM-
CSF was obtained from R&D Systems, recombinant mouse (rm)
GM-CSF was purchased from Peprotech and RU-486, and
AS605240 were purchased from Sigma. The broad spectrum
PI3K inhibitors LY294002 and wortmannin were obtained from
Calbiochem and Sigma respectively; the pan PI3K Class I
inhibitor PI-103 was purchased from Caymen Chemicals, Class
IA PI3K isoform–selective inhibitors were as previously described
[10]. The following compounds were provided by Novartis, NVS-
PI3-3 (p110d selective), HBC 417 (p110b selective), NVS-PI3-2
(p110a selective) and NVS-PI3-4 (p110c selective). The IC50
values for each isoform-selective PI3K inhibitor (in vitro kinase
assays) are listed in Table 3. The structures of NVS-PI3-2-4 and
HBC-417 are given in Figure 1. HBC-417 is now commercially
available as HY-75124 from Chemexpress. The concentration
response curves for NVS-PI3-3 and NVS-PI3-4 on the neutrophil
respiratory burst generated as described in [10] are shown in
Figure 2.
Antibodies, Reagents and Equipment
Rat anti-mouse antibody to CD2 (clone RM2-5), CD5 (clone
53-7.3), and CD45R (clone RA3-6B2) were purchased from BD
PharMingen (Oxford, UK). Rat anti-mouse F4/80 Ag (Clone A3-
1) and CD115 (clone 604B5 2E11) were purchased from Serotec
(Kidlington, U.K.). Goat anti-rat IgG microbeads, quadroMACSH
separator and LD columns were obtained from Miltenyi Biotec
(Bisley, UK). Primary monoclonal antibody to total Akt rabbit
mAb and Phospho-Akt (Ser473) rabbit mAb were obtained from
Cell Signaling Technology. Annexin V-FITC and propidium
iodide were purchased from BD Bioscience. Heat inactivated Fetal
Bovine Serum (FBS) was purchased from Bioclear (Wiltshire, UK).
Roswell Park Memorial Institute medium-1640 (RPMI) was
obtained from Invitrogen (Auckland, NZ). All other reagents were
as previously described [22].
Statistical Analysis
Results were analyzed using Predictive Analytics SoftWare
(PASW) Statistics 18.0.2 software and expressed as mean 6 SEM
of (n) separate experiments. Analysis of variance (ANOVA)
analysis followed by Tukey HSD (Honestly Significant Difference)
post-hoc tests was used to compare data and generate p values,
p#0.05 was considered significant.
Results
Inhibition of Multiple Class I PI3K Isoforms is Necessary to
Abrogate the rhGM-CSF Cytoprotective Effect in Human
Neutrophils
GM-CSF delays human neutrophil apopotosis (Figure 3A); our
initial experiments confirmed that LY294002 at a concentration of
10 mMprevented rhGM-CSF-mediated human neutrophil survival
without affecting the extent of constitutive neutrophil apoptosis
(Figure 3B). However, whilst 10 mM LY294002 is regarded as
a ‘standard’ inhibitor concentration to block Class I PI3K activity,
and will effectively inhibit all three Class IA isoforms, the IC50 for
PI3Kc has been measured as 7.26 mM [24]. Furthermore, 10 mM
LY294002will inhibit the catalytic activity of PI3KClass IIB and III
[25] as well as several non-lipid kinases including mTOR
(mammalian target of rapamycin), DNA-PK (DNA-dependent
protein kinase) [26] and Pim-1, whose expression is induced byGM-
CSF [27] and which can phosphorylate the pro-apoptotic protein
BAD leading to inhibition of apoptosis [28]. Thuswe speculated that
10 mM LY294002 may not inhibit PI3Kc fully, and may inhibit
other pathways relevant to apoptosis/survival. Wortmannin
(100 nM) also blocked the anti-apoptotic effect of GM-CSF,
although less completely than 10 mM LY294002 (see Figure 3B);
wortmannin at this concentration would be predicted to inhibit all
Class I PI3Ks; however, like LY294002, it also inhibits Class IIB and
III PI3Ks, and additionally is unstable in aqueous solutions,
necessitating inhibitor replenishment during the 20 hour time
course of this experiment.
Table 2. Murine full blood counts with differential leukocyte
count.
Parameter C57BL/6 PI3Kc2/2 PI3K dD910AcKO
Total WBC (x106/mm3) 7.1560.59 6.8261.4 6.0160.94
Lymphocytes (%) 74.160.14 54.865.21 55.863.00
Monocytes (%) 12.160.14 7.2061.42 9.4060.60
Neutrophils (%) 11.560.71 25.662.29 23.261.57
Eosinophils (%) 0.7560.35 8.9161.73 11.161.59
Basophils (%) 0.5060.50 0.6260.58 0.5360.71
Haemoglobin (g/dl) 14.060.70 13.862.61 13.361.72
MCV (fl) 50.960.03 51.660.57 52.460.71
Platelets (x106/mm3) 862636.0 9546246 10346135.0
Peripheral blood cell counts for 12 week-old C57BL/6 (n = 12), p110cKO (n = 4)
and p110dKOcKO (n = 3) mice on C57BL/6 background using an automated
Hematology Cell Counter. Similar results were obtained by blood films (data not
shown). Values are given as the mean 6 SD. WBC, white blood cells.
doi:10.1371/journal.pone.0045933.t002
Table 3. In vitro IC50 (mM) of small molecule
phosphoinositide 3-kinase inhibitors.
PI3K inhibitor p110a p110b p110d p110c
LY294002 0.70 0.306 1.33 7.26
Wortmannin 0.001 0.01 0.005 0.009
PI-103 (pan class I)* 0.0008 0.088 0.048 0.15
YM-024 (a and d) 0.3 2.65 0.33 9.07
TGX-221 (b) 5 0.007 0.10 3.5
IC87114 (d) .100 75 0.50 29
AS605240 (c)* 0.06 0.27 0.3 0.008
NVS-PI3-2 (a) 0.075 5.5 0.98 2.4
HBC-417 (b)* 0.38 0.007 0.03 0.2
NVS-PI3-3 (d) 0.180 0.60 0.003 0.31
NV3-PI3-4 (c) 1.8 0.25 0.75 0.09
Data compiled from published work: LY294002, wortmannin, PI-103, YM-024,
TGX-221, IC87114, AS605240.
Data generated by scintillation proximity assay performed in a final volume of
50 mL per well using a final concentration of ATP and PI in the assay of 5 mM
and 6 mg/mL respectively: NVS-PI3-2, HBC-417, NVS-PI3-3, NVS-PI3-4.
*Poor cell accessibility.
doi:10.1371/journal.pone.0045933.t003
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To explore further whether the effects of LY294002 and
wortmannin on GM-CSF-mediated neutrophil survival might
relate to off-target effects, we used PI-103, which potently and
competitively inhibits all PI3K Class I isoforms with an IC50 in the
submicromolar range as well as DNA-PK and mTOR, but not
any other of a panel of 317 other kinases [29]. Although at high
concentrations (10 mM), PI-103 did indeed appear to inhibit the
effects of rhGM-CSF on neutrophil apoptosis as determined by
annexin V staining (Figure 3B), morphological assessment of
neutrophils treated with rhGM-CSF and PI-103 did not reveal
classical apoptotic morphology. Surprisingly, in cells treated with
PI-103 at 1 mM or above, extensive cytoplasmic vacuolation was
seen, which was not apparent in vehicle control or LY294002
treated cells (Figure 4). Although inhibitor studies using LY294002
and wortmannin predict that PI3K inhibition should result in
reduced cell survival, in recent studies PI-103 did not induce
apoptosis in normal CD34+ cells or glioma cells [30,31];
furthermore, treatment of glioma cell lines with PI-103 led to
vacuolation and LC-3 processing [32], suggesting that a form of
cell death with features of autophagy rather than apoptosis may be
induced in some cell types by this inhibitor. However, electron
micrographs of human neutrophils treated with PI-103 demon-
strated that the vacuoles although abundant were bounded by
single, rather than double membranes, suggesting that this
inhibitor does not induce true autophagy in human neutrophils
(data not shown). In view of the unexpected effects of PI-103, we
decided to explore the effect of isoform-selective PI3K inhibitors
on cytokine-mediated neutrophil survival.
Figure 2. Effect of NVS-PI3-4 and NVS-PI3-3 on Neutrophil Oxidative Burst. Human neutrophils were suspended at 46106/ml in HBSS at
37uC and either primed with TNFa 10 ng/ml or treated with vehicle control, prior to the addition of NVS-PI3-4 (A) or NVS-PI3-3 (B) at the indicated
concentrations. Luminol and HRP (1 mM and 62.5 U/ml final concentrations respectively) were added and aliquots (150 ml) transferred to a pre-
warmed 96-well luminometer plate. fMLP (100 nM final concentration) was added via the injection port of a CentroPhago luminometer (Berthold
Technologies, Hertfordshire, UK) and light emission was recorded over 5 min. Triangular symbols represent TNFa-primed cells; unprimed cells
depicted by squares.
doi:10.1371/journal.pone.0045933.g002
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A selection of PI3K Class I isoform selective inhibitors were
used either individually or in combination, at carefully chosen
concentrations at or above their reported in vivo IC50 to inhibit
PI3K a/d (3 mM YM024), b/d (10 mM TGX221), d (3 mM
IC87114) or c (3 mM AS605240) (Figure 3B). Inhibition of any
individual Class I isoform failed to abrogate GM-CSF mediated
survival; however, the combination of 3 mM YM024 and 10 mM
TGX221 (which together inhibit PI3Ks a, b and d) blocked the
survival effect to the same extent as 10 mM LY294002. To confirm
these results, we used an additional independent group of isoform
selective PI3K inhibitors (see Figure 1), again used at or above the
IC50 for of the individual isoform (PI3Ks a (1 mM NVS-PI3-2),
b (1 mM HBC-417; at this concentration this compound will also
inhibit PI3K d), d (1 mM NVS-PI3-3) or c (1 mM NVS-PI3-4); in
the case of NVS-PI3-3 and NVS-PI3-4, the selected concentra-
tions were shown to be at or above the IC50 for inhibitions of the
TNFa-primed (NVS-PI3-3) or unprimed (NVS-PI3-4) fMLP-
stimulated neutrophil oxidative burst (Figure 2). For HBC-417
and NVS-PI3-2, the selected concentrations were based on the
IC50 values for these compounds in cell-based assays (inhibition of
PKB phosphorylation in Rat1 cells transfected with the relevant
PI3K isoform). In agreement with the above results, inhibition of
Figure 3. Inhibition of multiple Class I PI3K isoforms is required to abrogate the rhGM-CSF cytoprotective effect in human
neutrophils. A. Human neutrophils were incubated in IMDM +10% autologous serum in the presence (closed symbols) or absence (open circles) of
rhGM-CSF 10 ng/ml for 6–24 h. Neutrophil apoptosis was quantitated after 20 hours of culture by flow cytometry following AnV and PI staining. Data
represent %AnV positive cells (PI negative plus PI positive). Data represent n = 2 independent experiment performed in triplicate. B. Human
neutrophils (56106/ml) were pre-incubated for 20 mins in IMDM +10% autologous serum containing the indicated inhibitors or vehicle control
(DMSO), prior to treatment with rhGM-CSF 10 ng/ml. Neutrophil apoptosis was quantitated after 20 hours of culture by flow cytometry following AnV
and PI staining. C. Human neutrophils (56106/ml) were pre-incubated for 20 mins in IMDM +10% autologous serum containing the indicated
inhibitors, individually or in combination or vehicle control (DMSO concentration equivalent to that applied with the combination of all four isoform-
selective inhibitors). Cells were then treated with rhGM-CSF 10 ng/ml and apoptosis was quantitated after 20 hours of culture by flow cytometry
following AnV and PI staining. For B and C, data represent results of three independent experiments, performed in triplicate, expressed as mean %
apoptotic neutrophils 6 SEM values. *p,0.01 versus GM-CSF treatment alone; ns indicates no significant difference compared with GM-CSF alone.
doi:10.1371/journal.pone.0045933.g003
Figure 4. Light microscopy of human neutrophils treated with PI-103 and rhGM-CSF. Human neutrophils (56106/ml) were pre-incubated
for 20 minutes in Iscove’s Modified Dulbecco’s medium (IMDM) and 10% autologous serum containing 0.1% DMSO, LY294002 (10 mM) or PI-103
(10 mM) prior to treatment with rhGM-CSF (10 ng/ml). Neutrophil apoptosis was assessed at 20 hours by morphology. Representative
photomicrographs (x100) from 3 independent experiments of typical cytospins for each condition are shown. Results are representative of three
independent experiments performed in triplicate.
doi:10.1371/journal.pone.0045933.g004
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any single Class PI3K isoform using these compounds failed to
affect GM-CSF-mediated survival, as did targeting any two
isoforms in combination (Figure 3C). Once again, combined
inhibition of PI3K a, b and d was equivalent to the effect observed
with 10 mM LY294002; unexpectedly, inclusion of the selective
PI3Kc inhibitor NVS-PI3-4 in combination with any two other
Class IA PI3K inhibitors was likewise equally effective (Figure 3C).
Importantly, none of the inhibitors used affected the rate of
constitutive neutrophil apoptosis, either at 20 h or at 6 h, indicating
that the cells under study were unprimed and that the compounds
used even in combination were not toxic (Figure 3B and data not
shown). For all inhibitor studies, the results obtained using flow
cytometry were confirmed by independent morphological assess-
ment (data not shown). These data suggest that all Class I PI3K
isoforms may contribute to GM-CSF-mediated neutrophil survival,
and that suppression of overall Class I PI3K activity below a certain
threshold is required to abrogate this survival effect.
Abrogation of rhGM-CSF-induced PKB Phosphorylation
Requires Inhibition of Multiple PI3K Class I Isoforms
PKB is a downstream effector of the PI3K pathway, which has
been implicated in neutrophil survival. The effect of rhGM-CSF
(10 ng/ml) on the expression of cytosolic total and phosphorylated
PKB was measured using Western blot analysis. PKB phosphor-
ylation was rapid (as early as 30 seconds, data not shown) and
transient (peak effect at 5 minutes with diminution to baseline by
60 minutes, Figure 5A). GM-CSF-induced PKB phosphorylation
was abolished by pre-incubating the cells with broad spectrum
PI3K inhibitors LY294002 or wortmannin prior to treatment with
rhGM-CSF, and also by PI-103, but was not reduced significantly
by any individual isoform-selective PI3K inhibitor (Figures 6B and
6C), consistent with the lack of effect of these latter compounds on
neutrophil apoptosis (Figures 3A and 3B). In keeping with the
combinatorial effects of these inhibitors on growth factor-mediated
neutrophil survival described above, only the use of isoform-
selective inhibitors together to target either Class I or Class IA
PI3Ks abolished GM-CSF-mediated PKB phosphorylation
(Figures 6B and 6C). In agreement with the effect of the selective
PI3Kc inhibitor HB-522 on neutrophil apoptosis, this agent alone
had no effect on PKB phosphorylation but did have additive
effects on this response when combined with either both a and b or
a and d inhibitors (Figure 5D). Of note, a substantial (although not
complete) reduction in PKB phosphorylation was achieved by
inhibition of any two isoforms (Figure 5D and data not shown)
without an accompanying effect on neutrophil apoptosis. These
data, together with experiments that show the PKB inhibitor
AKT-i1/2 suppresses GM-CSF-mediated neutrophil survival
(Figure 6) suggest that near-complete (,85%) inhibition of GM-
CSF-induced PKB phosphorylation is required to abrogate the
GM-CSF mediated survival effect.
Murine Peripheral Blood Neutrophils Undergo Time-
dependent Apoptotic Cell Death, which is Delayed by
rmGM-CSF
The inhibitor studies described above suggest the possibility of
major functional redundancy between all Class IA and IB PI3K
isoforms. We wished to rule out the possibility that these results
were due to off-target inhibitor effects or to poor cellular
accessibility of the compounds, hence we used neutrophils from
knockout mice lacking individual PI3K isoforms. To overcome the
heterogeneous state of maturity of neutrophils obtained from
murine bone marrow, and the variable purity of such cells (both of
which variables would confound assessment of neutrophil apopto-
sis), we refined the previously described methodology [23] to allow
consistent isolation of murine peripheral blood neutrophils from
C57BL/6 wild type mice to 9065% purity and 98% viability. We
then characterized constitutive and rm-GM-CSF-modulated
apoptosis in these purified mature circulating murine neutrophils
cultured in RPMI supplemented with 10% FBS. Neutrophil cell
death was assessed after 0, 4, 6, 8 and 12 hours in culture using
two complementary techniques, standard morphological assess-
ment (Figure 7A) and flow cytometry (Figure 7B) with annexin V-
FTIC and propidium iodide staining.
Murine peripheral blood neutrophils underwent time-depen-
dent cell death, at a rate more rapid than that observed in human
cells (Figure 7). After 4–6 hours of incubation, PS exposure
accelerated rapidly in control cells, with nearly 60% of neutrophils
becoming annexin V positive at this time point, as measured by
either flow cytometry (Figure 7B) or confocal fluorescence
microscopy (Figure 7C). We also used JC-1 to study mitochondrial
membrane potential in cultured murine neutrophils; within 2
hours of culture a shift from red (mitochondrial) to green
(cytoplasmic) fluorescence was observed indicating collapse of
the mitochondrial potential consistent with early apoptosis
(Figure 7D). Murine neutrophil apoptosis was again significantly
delayed by rmGM-CSF in a concentration-dependent manner at
all time points studied (Figure 7E and 7F). Of note, murine
neutrophils were shown to be exquisitely sensitive to rmGM-CSF
with an EC50 of 7.5 pg/ml (Figure 7E). A concentration of 0.1 ng/
ml rmGM-CSF was therefore used in all subsequent experiments,
which produced a consistent and powerful cytoprotective effect.
Functional Redundancy of Class I PI3Ks in Mediating the
Cytoprotective Effect of GM-CSF in Murine Peripheral
Blood Neutrophils
The broad spectrum PI3K inhibitor LY294002 was used
initially to confirm that the rmGM-CSF mediated survival of
peripheral blood neutrophils from C57BL/6 mice was PI3K-
dependent (Figure 8A). LY294002 abrogated the rmGM-CSF
cytoprotective effect at 8 hours in a concentration-dependent
manner, with a maximal (and complete) effect observed at 10 mM
(Figure 8A). LY294002 had no effect on the rate of constitutive
murine neutrophil apoptosis nor did it induce vacuole formation
or necrosis, either at 8 h (Figure 8A) or at 4 h (data not shown). PI-
103 also blocked the rmGM-CSF survival effect in a concentration-
dependent manner with maximal effect achieved at 3 mM
(Figure 8B); unlike human cells, murine neutrophils did not
exhibit significant vacuolation on morphological assessment (data
not shown) although this response was observed in the small
number of contaminating monocytes within these preparations.
PI-103 did not affect constitutive apoptosis at either 8 h (Figure 8B)
or 4 h (data not shown).
Next, we assessed the rate of constitutive and GM-CSF-
modulated apoptosis in neutrophils derived from mice lacking
PI3Kc (p110cKO), or lacking both PI3Kc and PI3Kd
(p110dKOcKO). As reported previously [11], significant differences
were observed between peripheral white blood counts in C57B6
and p110cKO and p110dKOcKO transgenic strains (Table 2).
Importantly however, the rate of constitutive neutrophil apoptosis
was identical in wild type and p110cKO and p110dKOcKO mice;
moreover, there was no difference in the magnitude of the rmGM-
CSF survival response (Figure 8C). This is entirely consistent with
the lack of effect of dual inhibition of PI3Kc and PI3Kd on GM-
CSF-mediated neutrophil survival seen in human cells (Figure 3C).
We then explored whether p110cKO or p110dKOcKO neutro-
phils display increased sensitivity to PI-103 in the presence of
rmGM-CSF (Figure 8C). PI-103 0.3 mM had no effect on rmGM-
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CSF-induced survival of wild type neutrophils but attenuated the
rmGM-CSF survival effect in neutrophils from p110cKO and
p110dKOcKO mice (Figure 8C). The fact that p110cKO neutro-
phils were equally sensitized to inhibition of Class IA isoforms as
were cells which additionally lacked p110d, provided further
evidence for a role for PI3Kc in mediating GM-CSF-induced
neutrophil survival.
The Transient Inhibition of Constitutive Neutrophil
Apoptosis Observed ex vivo during an Exacerbation of
COPD is not Sensitive to PI3K Inhibition
Since pharmacological acceleration of neutrophil apoptosis has
been shown to promote the resolution of inflammation [6], we
wished to explore the relevance of PI3K signaling in a disease-based
setting. Since aberrant neutrophil survival may contribute to COPD
pathogenesis [33], we studied cells obtained from patients during
acute exacerbations of this condition. The extent of spontaneous
neutrophil apoptosis observed ex vivo in patients admitted to hospital
with an acute exacerbation of COPD was significantly reduced in
comparison to the values obtained for the same patients following 4–
7 days ofmedical treatment (Figure 9); for comparison, the values for
n = 7 healthy controls are shown in Figure 9, although we note that
these cells were not isolated in parallel with the patient samples and
that the healthy volunteers were not matched with the patients with
regards to age and smoking habit. The lack of effect of the
glucocorticoid receptor antagonist RU-486 suggested that the
measured reduction in neutrophil apoptosis rates was not due to
systemic corticosteroid treatment. We explored whether PI3K
signals the acute pro-survival phenotype seen during COPD
exacerbations and found that isoform selective PI3K inhibitors
(alone or in combinations) and also LY294002 failed to restore the
ability of exacerbating patient-derived neutrophils to undergo
apoptosis in a timely fashion. The same cells remained fully sensitive
to 10 ng/ml rhGM-CSF, which caused a fully PI3K-dependent
additional survival effect (Figure 9). Thus the COPD ‘‘survival
signal’’ for circulating neutrophils is transduced via a PI3K-in-
dependent pathway.
Discussion
Apoptosis is a key determinant of neutrophil persistence in
tissues during inflammatory disease states. We present evidence
that growth factor-mediated survival of mature circulating human
(and murine) neutrophils, whilst PI3K-dependent, shows complete
or near-complete functional redundancy with regard to all known
Class I PI3K isoforms.
Although enriched in PI3Ks d and c, neutrophils also express
abundant amounts of PI3Ka and b. Whilst the latter isoforms play
Figure 5. Combined inhibition of all Class IA PI3Ks abrogates rhGM-CSF mediated PKB phosphorylation. A. Human neutrophils
(56106/ml) were incubated in IMDM +10% autologous serum and treated with rhGM-CSF (10 ng/ml) for 2, 5, 15, 30 and 60 mins or with fMLP
(100 ng/ml) for 2 min as a positive control. Cells were lysed and the lysates subjected to Western blotting for total and phosphorylated PKB exactly as
described. A representative immunoblot of n = 3 is shown. B. The effect of PI3K inhibition was determined by pre-incubating neutrophils with the
indicated inhibitors for 20 minutes at 37uC prior to treatment with rhGM-CSF for 10 minutes prior to blotting for total and phosphorylated PKB. A
representative immunoblot of n = 3 independent experiments is shown. C. Western blots from the experiments describe in B. above were scanned
and analyzed using the Aida Image Analyzer 3.27 software package. Data represent mean 6 SEM of 3 independent experiments. Class 1A represents
YM-024 plus TGX-221 and IC87114; Class 1 as for Class 1A with the addition of AS605240. *p,0.01 versus GM-CSF alone, ns = not significantly
different from GM-CSF alone. D. Human neutrophils (56106/ml) were incubated with the indicated PI3K inhibitors alone or in combination for 20
minutes at 37uC prior to treatment with rhGM-CSF for 10 minutes. Lysates were blotted for total and phosphorylated PKB as described. A
representative immunoblot of n = 3 independent experiments is shown.
doi:10.1371/journal.pone.0045933.g005
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a key role in non-haemopoeitic cell survival/apoptosis, the
situation in hemopoeitic cells is less clear. Class IA but not IB
PI3K inhibitors were found to induce apoptosis in chronic
lymphatic leukemia cells [34], whilst inhibition of PI3Kb or
PI3Kd triggered apoptosis in acute promyelocytic leukemic cells
[24]. Somewhat surprisingly, over-expression of p101, which
resulted in constitutive PI3Kc activation in T cell lines, conferred
resistance to UV-induced apoptosis [35], thus there is a precedent
Figure 6. Effect of Akt inhibition on rhGM-CSF-mediated neutrophil survival and AktSER473 phosphorylation. Human neutrophils
(56106 cells/ml) were pre-incubated with either increasing concentrations of Akt1/2i, with 100 nm wortmannin, or with DMSO vehicle, for 20 minutes
prior to treatment with 10 ng/ml rhGM-CSF or vehicle in IMDM supplemented with 10% autologous serum. A. Neutrophil were incubated with Akt1/
2i at the indicated concentrations in the absence (open circles) or presence (closed circles) of rhGM-CSF 10 ng/ml. Apoptosis was assessed at 20 hours
by morphology. * denotes p,0.05 for cells treated with Akt1/2i and GM-CSF versus cells treated with GM-CSF alone. B. Lysates from cells prepared as
above were subjected to Western blotting for total and phosphorylated PKB. A representative immunoblot is shown. C. Densitometric analysis of
n = 3 Western blots from B. *p,0.05 and **p,0.01 versus GM-CSF alone.
doi:10.1371/journal.pone.0045933.g006
Regulation of Neutrophil Apoptosis by PI3Ks
PLOS ONE | www.plosone.org 11 September 2012 | Volume 7 | Issue 9 | e45933
for PI3Kc-derived PIP3 to signal for enhanced immune cell
survival. PI3Kc was also implicated in a study of constitutive
neutrophil apoptosis [16], but these authors did not utilize
isoform-selective PI3K inhibitors or neutrophils lacking individual
PI3K isoforms. Using these tools, we have shown that inhibition of
PI3Kc (and indeed other PI3K isoforms) in human neutrophils
and deletion of PI3Kc either alone or with PI3Kd in murine
neutrophils does not affect constitutive neutrophil apoptosis;
additionally, neither combinations of selective inhibitors nor the
non-selective Class I PI3K inhibitor LY294002 modulated basal
neutrophil lifespan. Thus we have shown unequivocally that PI3K
activity does not regulate constitutive neutrophil apoptosis under
our conditions.
Early reports indicated that deletion of individual PI3K isoforms
in mice led to complete inhibition of specific cellular functions, but
subsequent studies have often revealed complex and context-
dependent involvement of other isoforms, with a surprising degree
of cross-talk between Class IA and Class IB enzymes. For example,
mouse neutrophils lacking functional PI3Kc exhibited profound
reductions in neutrophil chemotaxis, recruitment to inflammatory
foci, and respiratory burst activity [11–13]. However, other
investigators subsequently demonstrated that, depending on the
inciting stimulus, PI3Kd also plays a significant role in neutrophil
chemotactic responses [17], recruitment [18], and in the human
respiratory burst when stimulated by G-protein coupled agonists
[10]. More recently, it has been shown that PI3Ks b, d and c all
play significant roles downstream of neutrophil FccRs, with a more
Figure 7. Murine peripheral blood neutrophils undergo time dependent cell death which is delayed by rmGM-CSF. Murine peripheral
blood neutrophils (16106/ml) were cultured in RPMI, 10% heat inactivated FBS with 20 mM HEPES, and penicillin and streptomycin (100 U/L), and
apoptosis was assessed after 0–12 hours in culture. A. Morphology at 0, 4 and 8 hours (vehicle control) and 8 hours (0.1 ng/ml rmGM-CSF);
representative photomicrographs (x40) of cytocentrifuge preparations stained with DiffQuickTM. Examples of apoptotic neutrophils are indicated by
arrows. B. Representative flow cytometry profiles following AnV/PI staining. Neutrophils cultured for 0, 4 and 8 hour (vehicle control) and 8 hour
(0.1 ng/ml rm-CSF). The percentage of neutrophils falling within each quadrant is indicated. C. Representative confocal images of murine peripheral
blood neutrophils cultured for 4 or 8 hours and stained with An/PI as described in Methods. D. Representative confocal images of murine peripheral
blood neutrophils incubated with JC-1 (0 or 2 hours). The dye localizes in intact mitochondria as red-shifted ‘‘J-aggregates’’; loss of mitochondrial
potential results in formation of JC-1 monomers and changes its emission to green. E. Murine peripheral blood neutrophils were incubated with
vehicle or with rmGM-CSF at the concentrations indicated for 8 hour and apoptosis determined by AnV/PI staining quantified by flow cytometry
(open circles). Data represent results of three independent experiments, performed in duplicate, expressed as mean % apoptotic neutrophils 6 SEM.
*p,0.01 compared with vehicle control-treated cells. F. Murine peripheral blood neutrophils were incubated with vehicle (open circles) or with
rmGM-CSF 0.1 ng/ml (closed circles) for the indicated times and apoptosis was determined by AnV/PI staining quantified by flow cytometry. Data
represent results of three independent experiments, performed in duplicate, expressed as mean % apoptotic neutrophils 6 SEM. *p,0.01compared
with control values.
doi:10.1371/journal.pone.0045933.g007
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selective role for PI3Kb at lower levels of stimulation [19]. PI3Kb
and d have also been shown play redundant roles in neutrophil
activation by Aspergillus hyphae [36]. Further, in murine
macrophages, PI3Kb is activated predominantly by GPCRs and
is functionally redundant with PI3Kc [37]. From this and earlier in
vitro studies [38,39] it is clear that there is considerable cross-talk
between the Class IA and Class IB PI3K signaling pathways.
Using two separate panels of isoform-selective Class I PI3K
inhibitors on human neutrophils, we have demonstrated that GM-
CSF-mediated survival is unaffected by inhibition of any 2, but
reversed by inhibition of any 3 of the 4 PI3K isoforms. Parallel
studies confirmed a stepwise reduction in PKB phosphorylation
with successive inhibition of increasing numbers of isoforms,
irrespective of the precise isoform(s) targeted. These results imply
that all 4 Class I PI3K isoforms are activated by ligation of the
GM-CSF receptor and that they provide a common signal, PIP3.
Further, if the main role of PIP3 in regulating survival is accepted
to be via activation of PKB, our measurements of PKB
phosphorylation suggest that only a fraction of the total PKB
phosphorylated in response to 10 ng/ml GM-CSF (approximately
15%) is required to drive neutrophil longevity. This is consistent
with our data indicating that near-complete abolition of PKB
phosphorylation by the AKT1/2 inhibitor is required to prevent
GM-CSF-mediated survival (Figure 6). However, it is also possible
that PIP3-dependent pathways other than PKB also participate in
signaling growth factor-mediated neutrophil survival.
Although we have previously demonstrated activation of PI3Kd
subsequent to, and dependent on, the activation of PI3Kc by
fMLP in human neutrophils [10], activation of PI3Kc in response
to ligation of the tyrosine kinase-linked GM-CSF receptor was
unexpected; hence we performed supernatant-transfer experi-
ments in the presence of GM-CSF neutralizing antibodies (data
not shown) but found no evidence of a transferable survival factor,
suggesting that activation of PI3Kc in this setting does not operate
through an autocrine loop. As discussed above, there are several
lines of evidence to support the occurrence of cross-talk between
PI3K Class 1A and Class 1B signaling pathways, but the precise
mechanism by which this occurs downstream of the GM-CSF
receptor is unclear at present and requires further investigation.
To circumvent the possibility that our interpretation of results
obtained using inhibitors with human neutrophils were confused
by ‘off-target’ effects, we employed neutrophils derived from the
peripheral blood of transgenic mice. Although there are significant
challenges in isolating these cells (the circulating mouse blood
volume is only 2 ml, and neutrophils comprise only 20–30% of
circulating leukocytes), the use of bone marrow neutrophils was felt
to be inappropriate for these experiments as the purity and
maturity of the myeloid cells obtained from this tissue is variable.
We acknowledge that human and murine neutrophils may differ
with regard to function and signaling [10]. Nonetheless, we found
that murine peripheral blood neutrophils underwent apoptosis ex
vivo in a manner analogous to that seen in human polymorpho-
Figure 8. Functional redundancy of class I PI3Ks in mediating the rmGM-CSF cytoprotective effect in murine peripheral blood
neutrophils. Peripheral blood neutrophils from C57BL/6 mice were pre-incubated in RPMI, 10% heat inactivated FBS with 20 mM HEPES, and
penicillin and streptomycin (100 U/L) with the indicated concentrations of A. LY294002 and B. PI-103 for 30 minutes at 37uC prior to treatment with
rmGM-CSF (0.1 ng/ml, closed circles) or vehicle (open circles). Apoptosis was assessed at 8 hours using flow cytometry following AnV and PI staining.
Data represent results of three independent experiments, performed in duplicate, expressed as mean % apoptotic neutrophils 6 SEM values.
*p,0.05 for LY294002 (A.) or PI-103 (B.) versus no inhibitor. C. Peripheral blood neutrophils (16106/ml) from C57BL/6, p110dKOcKO and p110cKO mice
were pre-incubated with 0.3 and 1 mM PI-103 or vehicle prior to treatment with rmGM-CSF (0.1 ng/ml) or vehicle. Apoptosis was assessed at 8 hours
using flow cytometry following AnV and PI staining. Data represent results of three independent experiments, performed in duplicate, expressed as
mean % apoptotic neutrophils 6 SEM. *p,0.05 for C57BL/6 versus p110dKOcKO and p110cKO.
doi:10.1371/journal.pone.0045933.g008
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nuclear cells, albeit more rapidly; likewise, the response to
cytokines and inhibitors was very similar to that of the
corresponding human cells. Thus our finding that murine
neutrophils lacking PI3Kc alone or both PI3Kc and PI3Kd
display normal constitutive and GM-CSF modulated apoptosis but
are sensitized when compared to wild type neutrophils with regard
to Class IA PI3K inhibition, supports the hypothesis that Class I
PI3Ks signal GM-CSF-mediated neutrophil survival in a function-
ally redundant manner.
The fact that mice lacking PI3Kc or PI3Ks c and d exhibit
peripheral blood neutrophilia despite normal constitutive neutro-
phil apoptosis rates is intriguing, since circulating neutrophil
numbers are tightly controlled by a range of homeostatic
mechanisms. As discussed by Stark et al. [40], mice deficient in
a range of leukocyte or endothelial adhesion molecules also display
a peripheral blood neutrophilia. An early suggestion that this
resulted simply from the inability of adhesion-deficient leukocytes
to egress from the circulation (passive accumulation) was not
supported by data using bone marrow chimeras [41]; instead,
Stark et al. have proposed that a failure of neutrophil trans-
migration into the tissues results in reduced ingestion of apoptotic
neutrophils by macrophages and dendritic cells, thereby failing to
suppress the secretion of IL-17 which is a stimulus for
granulopoeisis [40]. Whilst this hypothesis has not been tested in
PI3K knockout mice, inhibition of the PI3K-Akt axis was found to
inhibit macrophage production of IL-17 in a mouse model of
endotoxemia [42]. Thus despite normal rates of constitutive
neutrophil apoptosis, it is plausible that the failure of PI3Kc/
PI3Kcd-deficient neutrophils to migrate to the tissues prior to
undergoing local apoptosis may lead to the failure of this
important homeostatic mechanism.
Our results resemble those of Foukas et al. [20], but there are
a number of important differences between the two studies. Foukas
et al. employed murine hemopoietic progenitor cells derived from
mice lacking either PI3Ka or PI3Kd or both, immortalized by
transduction with a retrovirus encoding the proto-oncogene Hox1.
In these immortalized progenitor cells, activity of any Class IA
PI3K isoform was found to be sufficient to sustain proliferation or
survival, although no role was demonstrated or implied for PI3Kc.
By contrast we have studied un-manipulated human and murine
blood neutrophils which are terminally differentiated, non-di-
viding cells programmed to die by apoptosis; clearly the signaling
events which determine longevity in these cells might be expected
to differ from those supporting immortalized progenitor cells.
Since neutrophil apoptosis is a key factor in allowing the
resolution of inflammation in a range of inflammatory diseases,
pharmacological manipulation of neutrophil survival is regarded
as a potential therapeutic target [6]. However, our results would
suggest that even combined inhibition of PI3Kc and d (such dual
inhibitors have been proposed as powerful potential anti-in-
flammatory agents [43]) would not be sufficient to modulate the
survival signal imparted by a single cytokine or growth factor.
Since inflammatory diseases are characterized by an array of
circulating and locally generated cytokines, the prospect that
selective PI3K inhibitors will be able to modulate neutrophil
apoptosis in this setting seems increasingly remote. In keeping with
this view, neutrophils isolated from patients hospitalized with
exacerbations of COPD were extremely resistant to PI3K
inhibition in terms of survival. We chose to study COPD because
it is a major global cause of morbidity and mortality, and because
a previous study had suggested that neutrophils from patients
experiencing an exacerbation of COPD exhibit delayed apoptosis
[33]. We found that circulating neutrophils from patients early in
the course of disease did indeed show prolonged survival
compared to cells isolated from the same individual during the
recovery phase. However, the survival effect demonstrated could
not be reversed by inhibition of individual PI3Ks, by combined
inhibition of all four isoforms, or by LY249002 (Figure 9). During
an exacerbation of COPD, and in the majority of inflammatory
conditions, a wide range of circulating and tissue mediators may
influence the neutrophil function and lifespan, and this is not
readily reproduced in vitro.
In summary, we have demonstrated for the first time that there
is complete functional redundancy between Class I PI3K isoforms
in mediating the pro-survival signal imparted by GM-CSF to
mature circulating neutrophils, and that in a human disease state
characterized by delayed neutrophil apoptosis, this delay is not
modulated by PI3K inhibition. This suggests that alternative
strategies will be needed to modulate neutrophil apoptosis in
human disease in vivo.
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